Table 4.
Association Between Demographic, Social and Clinical Characteristics and 6-Month All Cause Readmission.
| Risk factors | No readmission N = 14 (%) |
≥1 Readmission N = 20 (%) |
P |
|---|---|---|---|
| Male | 9 (64.3%) | 10 (50%) | 0.41 |
| Uninsured | 6 (42.9%) | 16 (80%) | 0.03 |
| Spanish as Primary Language | 7 (50%) | 18 (90%) | 0.01 |
| Hispanic | 8 (57.1%) | 18 (90%) | 0.03 |
| History of substance abuse | 4 (28.6%) | 1 (5%) | 0.06 |
| History of mental health | 5 (35.7%) | 2 (10%) | 0.8 |
| First episode toxoplasmosis | 8 (57.1%) | 18 (90%) | 0.03 |
| Compliance with toxoplasmosis treatment | 12 (85.7%) | 9 (45%) | 0.02 |
| intensive care unit admission | 6 (42.9%) | 6 (30%) | 0.44 |
| Steroids | 8 (57%) | 12 (60%) | 0.73 |
| Midline shift on initial MRI | 3 (21.4%) | 8 (40%) | 0.25 |
| Concomitant opportunistic infection during initial admission | 11 (78.6%) | 10 (50%) | 0.09 |
| Need to change toxoplasmosis therapy due to adverse effect | 10 (71.4%) | 10 (50%) | 0.21 |
| Mean time to 1st follow up (SD*) | 35 (17.9) | 43 (45.3) | 0.52 |
| Median CD4 cell count (μ/L) at baseline (SD*) | 59.5 (42.2) | 36.7 (30.6) | 0.12 |
| Median CD4 cell count (μ/L) at 6 months (SD*) | 177.6 (82) | 114.6 (85.2) | 0.06 |
| Median Time (days) to HAART initiation (SD*) | 32.2 (19.2) | 216.7 (524.8) | 0.2 |
* SD = standard deviation.